Financials 3billion, Inc.

Stocks

End-of-day quote Korea S.E. 2026-10-23			5-day change	1st Jan Change
5,000.00 ^KRW	-5.12%		-5.12%	-72.57%

06-01	3billion Launches 3B-NEO, Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions	CI
05-12	3billion, Inc. announced that it has received KRW 29.9999999 billion in funding from Meritz Securities Co., Ltd., Wonik Investment Partners Co., Ltd.	CI

Fiscal Period: December	2024	2025	2026	2027
Net sales ¹	-	11.71	16	25
Change	-	-	36.65%	56.25%
EBITDA ¹	-	-4.005	-	-
Change	-	-	-	-
EBIT ¹	-	-5.889	-7	-4
Change	-	-	-18.86%	42.86%
Interest Paid ²	-	266	-	-
Earnings before Tax (EBT) ¹	-	-5.411	-	-
Change	-	-	-	-
Net income ¹	-6.572	-5.411	-	-
Change	-	17.66%	-	-
Announcement Date	3/21/25	2/11/26	-	-

¹KRW in Billions²KRW in Million

Estimates

Fiscal Period: December	2024	2025	2026	2027
Net Debt ¹	-	-4.78	-	-
Change	-	-	-	-
Announcement Date	3/21/25	2/11/26	-	-

¹KRW in Billions

Estimates

¹KRW in Million

Estimates

Fiscal Period: December	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-34.21%	-	-
EBIT Margin (%)	-	-50.3%	-43.75%	-16%
EBT Margin (%)	-	-46.22%	-	-
Net margin (%)	-	-46.22%	-	-
FCF margin (%)	-	-49,987.33%	-	-
FCF / Net Income (%)	-	108,159.72%	-	-
Profitability
ROA	-	-18.07%	-	-
ROE	-	-20.87%	8.8%	-14.7%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-
Debt / Free cash flow	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	19.6%	-	-
CAPEX / EBITDA (%)	-	-57.29%	-	-
CAPEX / FCF (%)	-	-0.04%	-	-
Items per share
Cash flow per share ¹	-	-	-	-83
Change	-	-	-	-
Dividend per Share ¹	-	-	-	-
Change	-	-	-	-
Book Value Per Share ¹	-	744	819	714
Change	-	-	15.51%	-12.82%
EPS ¹	-234	-171	-	-
Change	-	26.92%	-	-
Nbr of stocks (in thousands)	31,684	31,823	31,823	31,823
Announcement Date	3/21/25	2/11/26	-	-